Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.840
+0.030 (1.66%)
At close: Jun 12, 2026, 4:00 PM EDT
1.840
0.00 (0.00%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $130.00K in the twelve months ending March 31, 2026, up 154.90% year-over-year. In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.
Revenue (ttm)
$130.00K
Revenue Growth
+154.90%
P/S Ratio
207.43
Revenue / Employee
$8,125
Employees
16
Market Cap
27.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.00K | 74.00K | 132.14% |
| Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
| Dec 31, 2023 | 3.15M | 3.12M | 9,173.53% |
| Dec 31, 2022 | 34.00K | -110.00K | -76.39% |
| Dec 31, 2021 | 144.00K | -217.00K | -60.11% |
| Dec 31, 2020 | 361.00K | -1.37M | -79.11% |
| Dec 31, 2019 | 1.73M | 332.00K | 23.78% |
| Dec 31, 2018 | 1.40M | -8.00K | -0.57% |
| Dec 31, 2017 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 12.88M |
| Kyntra Bio | 7.44M |
| Dyadic International | 3.81M |
| IGC Pharma | 1.11M |
| Pluri | 1.08M |
SER News
- 21 days ago - Serina Therapeutics files to sell 16.45M shares of common stock for holders - TheFly
- 4 weeks ago - Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - GlobeNewsWire
- 2 months ago - Serina Therapeutics announces NYSE acceptance of plan to regain compliance - TheFly
- 2 months ago - Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the 38th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Serina Therapeutics names Greg Bailey co-chairman - TheFly
- 3 months ago - Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease - GlobeNewsWire